Philip Clements
Overview
Explore the profile of Philip Clements including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Murphy S, Furst D, Clements P, Kafaja S, Tsevat J, et al.
J Scleroderma Relat Disord
. 2023 Jun;
8(2):107-112.
PMID: 37283281
Objectives: Systemic sclerosis often has a significant impact on an individual's quality of life. Life satisfaction is a subjective expression of well-being and a key component of quality of life....
2.
Scheiman-Elazary A, Ranganath V, Ben-Artzi A, Kafaja S, Borazan N, Woodworth T, et al.
J Scleroderma Relat Disord
. 2022 Apr;
3(3):228-236.
PMID: 35382015
Objectives: Validating musculoskeletal ultrasound features of the joints and tendons of the hands in a large scleroderma cohort. Methods: A total of 81 scleroderma patients participated in this prospective, cross-sectional...
3.
Goldin J, Kim G, Tseng C, Volkmann E, Furst D, Clements P, et al.
Ann Am Thorac Soc
. 2018 Sep;
15(11):1286-1295.
PMID: 30265153
Rationale: The Scleroderma Lung Study II (SLS II) demonstrated significant improvements in pulmonary function and dyspnea at 24 months compared with baseline when patients with symptomatic scleroderma-related interstitial lung disease...
4.
Constantin T, Foeldvari I, Pain C, Palinkas A, Hoger P, Moll M, et al.
Eur J Pediatr
. 2018 May;
177(7):961-977.
PMID: 29728839
Conclusion: Management of jLS is varied. These recommendations should help provide standardization of assessment and care for those with this rare and potentially debilitating condition. What is Known: • Children...
5.
Woodworth T, Suliman Y, Li W, Furst D, Clements P
Nat Rev Nephrol
. 2018 Jan;
14(2):137.
PMID: 29292373
This corrects the article DOI: 10.1038/nrneph.2016.124.
6.
Yan L, Pham D, Clements P, Lincoln S, Wang J, Guo X, et al.
Beilstein J Org Chem
. 2017 Oct;
13:1879-1892.
PMID: 29062407
Three aqueous self-assembling poly(acrylate) networks have been designed to gain insight into the factors controlling the complexation and release of small molecules within them. These networks are formed between 8.8%...
7.
Clements P, Allanore Y, Furst D, Khanna D
Rheumatology (Oxford)
. 2017 Oct;
56(suppl_5):v23-v26.
PMID: 28992165
Although musculoskeletal involvement is quite common in SSc (arthritic in particular), there have been few trials and even fewer controlled trials of therapeutic agents in arthritis in SSc. In addition,...
8.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al.
Ann Rheum Dis
. 2016 Dec;
76(8):1327-1339.
PMID: 27941129
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the previous...
9.
Woodworth T, Suliman Y, Li W, Furst D, Clements P
Nat Rev Nephrol
. 2016 Sep;
12(11):678-691.
PMID: 27641135
Scleroderma renal crisis (SRC) is a rare, potentially life-threatening complication that affects 2-15% of patients with systemic sclerosis (SSc, also known as scleroderma). SRC typically presents in patients with early,...
10.